SAM
CVS icon

Smartleaf Asset Management’s CVS Health CVS Stock Holding History

Smartleaf Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Hold
27,185
– – 0.09% 192
2026
Q1 		$1.91M Buy
27,185
+1,164
+4% +$89.7K 0.07% 251
2025
Q4 		$2.08M Buy
26,021
+5,636
+28% +$444K 0.08% 222
2025
Q3 		$1.54M Buy
20,385
+5,326
+35% +$365K 0.1% 235
2025
Q2 		$1.03M Buy
15,059
+164
+1% +$10.8K 0.09% 245
2025
Q1 		$1M Buy
14,895
+4,170
+39% +$250K 0.1% 231
2024
Q4 		$471K Buy
10,725
+760
+8% +$42.6K 0.05% 341
2024
Q3 		$612K Sell
9,965
-1,289
-11% -$75.2K 0.07% 271
2024
Q2 		$657K Buy
11,254
+2,829
+34% +$177K 0.11% 216
2024
Q1 		$669K Buy
8,425
+1,623
+24% +$124K 0.13% 183
2023
Q4 		$525K Buy
+6,802
New +$484K 0.14% 164

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Smartleaf Asset Management's CVS Position: Q2 2026 in Review

Smartleaf Asset Management held its CVS Health (CVS) position steady in Q2 2026 at 27,185 shares worth $2.82M. The position accounts for 0.09% of the portfolio, ranked #192.

Smartleaf Asset Management first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Smartleaf Asset Management held 27,185 shares of CVS Health worth $2.82M as of Q2 2026.
  • Smartleaf Asset Management left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.09% of Smartleaf Asset Management's portfolio in Q2 2026, its #192 holding.
  • Smartleaf Asset Management first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.